Alogliptin And Pioglitazone
Product manufactured by Perrigo New York Inc
Indications and Purposes
1 Indications And Usage Alogliptin And Pioglitazone Tablets Are A Dipeptidyl Peptidase-4 Inhibitor And Thiazolidinedione Combination Product Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus. ( 1.1 ) Important Limitations Of Use: Not For Treatment Of Type 1 Diabetes Or Diabetic Ketoacidosis. ( 1.1 ) 1.1 Monotherapy And Combination Therapy Alogliptin And Pioglitazone Tablets Are Indicated As An Adjunct To Diet And Exercise To Improve Glycemic Control In Adults With Type 2 Diabetes Mellitus When Treatment With Both Alogliptin And Pioglitazone Is Appropriate [See Clinical Studies (14) ]. Important Limitations Of Use Alogliptin And Pioglitazone Tablets Are Not Indicated For The Treatment Of Type 1 Diabetes Mellitus Or Diabetic Ketoacidosis, As It Would Not Be Effective In These Settings. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 2 Total)
Name | Structure | ZINC ID(s) |
---|---|---|
1. Alogliptin Benzoate |
|
ZINC1011 |
2. Pioglitazone Hydrochloride |
|
ZINC968326 |